Literature DB >> 7584975

The slowing of treatment discovery, 1965-1995.

R J Wurtman1, R L Bettiker.   

Abstract

Mesh：

Year:  1995        PMID： 7584975     DOI： 10.1038/nm1195-1122

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  6 in total

Review 1.  Diagnosing the decline in pharmaceutical R&D efficiency.

Authors:  Jack W Scannell; Alex Blanckley; Helen Boldon; Brian Warrington
Journal:  Nat Rev Drug Discov       Date:  2012-03-01       Impact factor: 84.694

2.  In vivo veritas: the continuing importance of discoveries in complex biosystems.

Authors:  C G Persson
Journal:  Thorax       Date:  1996-04       Impact factor: 9.139

3.  Public R&D Investments and Private-sector Patenting: Evidence from NIH Funding Rules.

Authors:  Pierre Azoulay; Danielle Li; Joshua S Graff Zivin; Bhaven N Sampat
Journal:  Rev Econ Stud       Date:  2018-06-15

4.  Decline in new drug launches: myth or reality? Retrospective observational study using 30 years of data from the UK.

Authors:  Derek J Ward; Orsolina I Martino; Sue Simpson; Andrew J Stevens
Journal:  BMJ Open       Date:  2013-02-20       Impact factor: 2.692

Review 5.  Insights into the biology of fibrodysplasia ossificans progressiva using patient-derived induced pluripotent stem cells.

Authors:  Taiki Nakajima; Makoto Ikeya
Journal:  Regen Ther       Date:  2019-05-10       Impact factor: 3.419

6.  Are medical breakthroughs declining - The importance of case reports?

Authors:  Sundeep Mishra
Journal:  Indian Heart J       Date:  2015-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.